Interesting article. I note Opthea has the option to prepay its obligations at any time.
Megan Baldwin is quoted several times.
”This strategic transaction is expected to fund us through Phase 3 top-line data expected in mid-2024 and strengthens our strategic position to maximise the value of OPT-302”
”One of the really good points about the financing is that you can be in a stronger position to move it forward independently. It means we can make the right choices and only do a partnership deal that is
good - we’re not forced into a position of needing to do any one kind of deal, we’re independently funding through to top-line data readout.”
”That said, we’re remain open to partnership, because we recognise you can leverage the expertise and resources of a large pharmaceutical partner.”
- Forums
- ASX - By Stock
- OPT
- News: OPT Opthea Ltd Says Offer Price For $90 Million Placement Is A$1.15 Per New Share
News: OPT Opthea Ltd Says Offer Price For $90 Million Placement Is A$1.15 Per New Share, page-6
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
49.3¢ |
Change
-0.003(0.51%) |
Mkt cap ! $609.3M |
Open | High | Low | Value | Volume |
49.5¢ | 49.8¢ | 49.3¢ | $10.07K | 20.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 39462 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 47 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 35793 | 0.490 |
6 | 26283 | 0.485 |
6 | 29997 | 0.480 |
8 | 56094 | 0.475 |
6 | 179560 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 10283 | 7 |
0.505 | 23551 | 7 |
0.510 | 41263 | 9 |
0.515 | 19390 | 6 |
0.520 | 84046 | 7 |
Last trade - 10.11am 20/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |